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Abstract
Background: Coronary artery disease (CAD) is among the main causes of death in developed countries, and diet
and lifestyle can influence CAD incidence.
Objective: To evaluate the association of coronary artery disease risk score with dietary, anthropometric and
biochemical components in adults clinically selected for a lifestyle modification program.
Methods: 362 adults (96 men, 266 women, 53.9 ± 9.4 years) fulfilled the inclusion criteria by presenting all the
required data. The Framingham score was calculated and the IV Brazilian Guideline on Dyslipidemia and Prevention
of Atherosclerosis was adopted for classification of the CAD risks. Anthropometric assessments included waist
circumference (WC), body fat and calculated BMI (kg/m
2) and muscle-mass index (MMI kg/m
2). Dietary intake was
estimated through 24 h dietary recall. Fasting blood was used for biochemical analysis. Metabolic Syndrome (MS)
was diagnosed using NCEP-ATPIII (2001) criteria. Logistic regression was used to determine the odds of CAD risks
according to the altered components of MS, dietary, anthropometric, and biochemical components.
Results: For a sample with a BMI 28.5 ± 5.0 kg/m
2 the association with lower risk (<10% CAD) were lower age
(<60 years old), and plasma values of uric acid. The presence of MS within low, intermediary, and high CAD risk
categories was 30.8%, 55.5%, and 69.8%, respectively. The independent risk factors associated with CAD risk score
was MS and uric acid, and the protective factors were recommended intake of saturated fat and fiber and muscle
mass index.
Conclusion: Recommended intake of saturated fat and dietary fiber, together with proper muscle mass, are
inversely associated with CAD risk score. On the other hand, the presence of MS and high plasma uric acid are
associated with CAD risk score.
Background
Coronary artery disease (CAD) is among the main
causes of death in developed countries, and it currently
occurs with greater frequency in developing countries,
especially among the elderly [1,2]. The Framingham
score was developed to estimate the CAD risk over
10 years and it was validated for people aged up to
75 years [3,4]. The PRINCEPS (Identification Program of
Cardiovascular Risk Level and Increase in Lipid Para-
meters) study conducted in Spain between 2004 and
2005 with more than 26,500 individuals of both genders
above 45 years of age, observed that established CAD
prevalence or CAD risk of 36.9% (n = 9829) [5]. This
same study found a prevalence of 34.9% (n = 9292) of
individuals with CAD risk higher than 20% in 10 years
[5].
CAD risk can be calculated from risk factors and the
presence of clinical signs and biochemical abnormalities
[6]. The Framingham risk score is often used as an
initial evaluation parameter of CAD risk in individuals
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bolic Syndrome (MS) [7].
The MS is a multiple risk factor for cardiovascular
disease and is characterized by increased waist circum-
ference, raised triglycerides, reduced HDL cholesterol,
elevated blood pressure, and raised plasma glucose [8,9].
From these, reduced HDL-c and elevated blood pressure
are common components of both CAD risk and MS.
Diet and lifestyle can influence CAD incidence [10].
A Mediterranean diet, rich in plant foods in combina-
tion with nonsmoking, moderate alcohol consumption,
and daily physical activity is associated with a signifi-
cantly lower mortality rate of CAD and all cause
mortality [11]. Some factors related to MS such as dys-
lipidemia, hyperglycemia, hypertension, obesity and
other risk factors like low levels of physical activity
and smoking [12] have already been well established as
CAD risk factors. However, most Brazilian studies
investigate the association of factors related to lifestyle
changes with CAD risk factors only individually
[13-16] (e.g., hypertension, diabetes, hypercholesterole-
mia); but no national study investigated the association
between CAD risk (Framingham score) and its direct
relationship with dietary components, biochemical and
body composition [17,18].
The aim of this study was to evaluate the association
of CAD risk score with anthropometric, biochemical
and dietary factors in adults with or without MS who
were clinically selected for a lifestyle modification
program.
Methods
Individuals
A descriptive cross-sectional study was conducted in a
subgroup of participants clinically screened for a lifestyle
modification program “Mexa-se Pró-Saúde [Move for
Health]”, from 2004 to 2007. This program is offered to
patients with non-communicable chronic diseases and
consists of regular physical exercise and nutritional
counseling. The Metabolism, Exercise and Nutrition
Center (CeMENutri), conducts this program since 1992,
in Botucatu. Botucatu is a city located in the center of
Sao Paulo State, about 230 km west of the capital city
and has a population of 121,274 in habitants [19]. The
inclusion criteria for participants were individuals over
the age of 35, of both genders, with at least one of the
MS components and/or comorbities, and without meta-
bolic or motor disabilities that would limit physical
exercise.
A total of 658 individuals were attended at the pro-
gram during this period. From those individuals, 362
individuals had CHD data and were studied. The study
included 96 men and 266 women, with age of 53.9 ± 9.4
a n dB M Io f2 8 . 5±5 . 0k g / m
2. Besides gender the
individuals were also distributed by age considering 60
years the cutoff for elderly. All had signed a term of
informed consent, and the project was approved by the
Research Ethics Committee (CEP protocol 3271-2009)
of the Botucatu Medical School (FMB), São Paulo State
University (UNESP, Brazil).
Clinical Evaluation of Arterial Blood Pressure
Systolic and diastolic arterial blood pressure was evalu-
ated with the individual in the seated position according
to the procedures described by the V Brazilian Guide-
lines on Arterial Hypertension [20]. Values of systolic
blood pressure ≥ 130 mm Hg and/or diastolic blood
pressure ≥85 mm Hg were considered abnormal.
Biochemical Analyses
Blood samples were collected after overnight fasting 10 to
12 hours using a vacuum venous puncture. The indivi-
duals were previously instructed to not perform vigorous
physical exercise 24 hours and/or not drink alcohol 72
hours before collection. Laboratory analyses of lipid para-
meters (total cholesterol, fractions and triglycerides), glu-
cose, uric acid, urea, g-glutamyl transferase (g-GT),
C-reactive protein (CRP), albumin and total proteins were
performed within 4 hours after blood collection using the
Dry Chemical method (Vitros
® system, Johnson & John-
son), at the Clinical Analyses Laboratory of the Teaching
Hospital (School of Medicine UNESP) in Botucatu/SP.
The non-high density lipoprotein cholesterol (nHDL-c)
values were obtained finding the difference between total
cholesterol (TC) and high density lipoprotein cholesterol
(HDL-c). Concentrations of triglycerides (TG) >150 mg/
dL [21], TC >200 mg/dL [22], HDL-c <40 mg/dL for men
and <50 mg/dL for women [21], glycemia ≥100 mg/dL
[23] and uric acid (higher quartile) ♂ >6 , 5m g / d La n d
♀ > 5 mg/dL) were considered abnormal [24,25].
Risk of Coronary Artery Disease (CAD)
In order to estimate the Framingham score and calculate
CAD risk over 10 years, the classification from the IV
Brazilian Guideline on Dyslipidemia and the Prevention
of Arteriosclerosis [22] was adopted. Individuals who
reported diabetes mellitus (type 1 or 2) through clinical
protocol were included in phase 1 of risk stratification,
which is considered a clinical manifestation equivalent to
arteriosclerotic disease. Thus, the population with dia-
betes has a 20% greater risk of presenting cardiovascular
events in 10 years. Phase 2 of the stratification considers
t h er i s kb ye s t i m a t i n gF r a m i n g h a ms c o r e s ,w h e r ea f t e r
adding the points obtained for each variable (gender, age,
systolic blood pressure, TC, HDL-C and smoking), the
absolute risk percentage in 10 years was calculated,
which can be classified as low risk (<10%), intermediate
risk (10 to 20%) and high risk (>20%).
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Body weight was measured on a platform anthropometric
scale (Filizola
®) with maximum capacity of 150 kg and
precision of 0.1 kg. Height was determined using a porta-
ble Seca
® stadiometer, with a precision of 0.1 cm [26].
After body weight and height was evaluated, BMI was
calculated (weight/height (m)
2) and classified [27].
Waist circumference (WC) was measured at the point
midway between the last rib and the iliac crest. All mea-
surements used the Sanny
® steel anthropometric tape
measure. Values in excess of 102 cm for men and
88 cm for women [25] were considered elevated.
Bioelectric impedance (Biodynamics
®, model 450,
USA) was used to determine the percentage of body fat
(%BF) and muscle mass (kg). Segal et al (1988) equation
was used to calculated the %BF [28]. Values ranging
between 15 and 25% and 20 and 35% for men and
women, respectively, were considered normal for
(%BF) [29]. The percentage of muscle mass (%MM) was
obtained using the Janssen et al., (2000) equation [30]
and the muscle mass index (MMI) was calculated as MM
(kg)/height
2. Individuals were classified as sarcopenic if
their values were below 10.75 kg/m
2 and 6.75 kg/m
2 for
men and women, respectively [31].
Metabolic Syndrome
Diagnosis of Metabolic Syndrome was made according
to the criteria of NCEP-ATP III [24,25]. The 5 compo-
nents used were plasma levels of triglyceride, HDL-C
and, fasting plasma glucose, systolic and diastolic blood
pressure and WC measurements. Metabolic syndrome
was diagnosed when 3 or more of these components
were abnormal.
Dietary Assessment
The 24 h dietary recall was used to assess food intake
[32]. Dietary data obtained in homemade measurements
were converted into grams and milliliters to permit che-
mical analysis of food intake. The centesimal composi-
tion of foods present in the records was calculated using
NutWin
® (2002) software, version 1.5. Foods not found
i nt h es o f t w a r ew e r ea d d e df r o md i v e r s ec o m p o s i t i o n
tables and food labels [33,34]. Diet quality was evaluated
using the Adapted Healthy Eating Index (HEI) [35] and
evaluated groups were based on portions recommended
by the Adapted Food Pyramid [36].
Statistical Analysis
The descriptive characteristics were presented as mean
and standard deviation, applying the ANOVA and
Tukey test to compare means. Regression models nega-
tive binomial were adjusted to characterize portions
intake. The Spearman correlation was used to evaluate
the correlation of demographic, anthropometric, dietary,
biochemical, systolic and diastolic blood pressure and
MS components with the Framingham risk score. Logis-
tic regression was used to determine the probability of
high CAD risk score (low+moderate vs high) according
to dietary (adjusted for TCV + BMI), and anthropo-
metric components, MS, CRP and uric acid concentra-
tion (adjusted for BMI). A value of p < 0.05 was
adopted as significant. The SAS program, version 9.1.3,
was used for data analysis.
Results
Table 1 shows the distribution of the variables’ average
values according to the seriousness of CAD risk score.
Individuals with the lower risk had the youngest age,
lowest waist circumference, lowest legume intake, lowest
triglyceridemia, uricemia and diastolic blood pressure
values, and highest concentrations of HDL-C. Indivi-
duals with the intermediate risk had the highest MMI,
total cholesterolemia, LDL-C and nHDL-C values, and
lowest CRP values. Individuals with the higher CAD risk
score had the highest energy intake and highest plasma
values for glucose and urea. The presence of MS within
low, intermediate and high CAD risk score categories
was 30.8%, 55.5% and 69.8%, respectively (data not
shown).
Table 2 shows the significant and stronger (r > 0.3)
correlations of demographic, anthropometric, dietary
and biochemical data with CAD risk score. Positive cor-
relations were observed with age, % energy from protein,
glucose, uric acid, SBP, DBP and number of MS compo-
nents. The only negative correlation was with HDL-c.
Odds Ratios for CAD risk score can be found in Table
3, high plasma uric acid and presence of metabolic syn-
drome were risk factors and muscle mass index a pro-
tective factor. Furthermore, recommended intake of
saturated fat (<10% TCV) and dietary fiber (>20g/day)
[21] acted as protective dietary factors for CAD risk
score, even after adjustments for BMI and TCV.
In general, besides the variables used to calculate CAD
risk score, muscle mass and recommended intake of
saturated fat and fiber were associated as protective fac-
tors, and the presence of metabolic syndrome was asso-
ciated as risk factor.
Discussion
As expected [9], in this study, CAD risk score increased
with age and was related to its diagnostic elements, SBP,
TC (nHDL-C) and HDL-C. Furthermore, a strong posi-
tive influence of MS and its components (WC, glucose
and TG) was observed in CAD risk score. From these,
blood pressure and HDL-c are less valid due to the fact
they are both CAD risk and MS diagnostic elements.
From the logistic regression analyses, individuals with
MS presented a fourfold greater probability of high
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methee et al., (2005) [37], where men with MS pre-
sented a relatively significant risk (RR 1.64; 95% CI;
1.26-2.06) for developing CAD compared to individuals
without MS.
The association between MS and CAD risk found in
this study was similar the one observed in studies con-
ducted in the United States [38,39] and Europe [40,41],
where they found a 2 to 3 times greater probability for
an increase in CAD risk in individuals with MS. A posi-
tive correlation was observed of CAD risk score and the
number of MS components, that is, the greater the
number of MS components the higher the risk of devel-
oping CAD.
Table 1 Demographic, anthropometric, dietary and
biochemical characteristics of the sample according to
CAD risk score classification in free-living adults
Low Risk Intermediate
Risk
High Risk
Age (years) 52.1 ± 8.9
a 59.4 ± 8.1
b 56.6 ± 9.9
b
BMI (kg/m2) 28.3 ± 5.1
a 28.8 ± 4.6
a 29.1 ± 5.0
a
% Body Fat 32.4 ± 8.8
a 30.3 ± 6.9
a 31.9 ± 7.6
a
Waist circumference
(cm)
94.6 ± 12.3
a 100.6 ± 14.0
b 100.0 ± 13.2
b
Muscle Mass Index
(kg/m
2)
8.1 ± 1.4
a 9.3 ± 1.7
b 8.4 ± 1.5
a
Total energy intake
(kcal)
1538 ± 484
a 1600 ± 470
a 1920 ± 912
b
HEI (points) 84.3 ± 13.6
a 83.0 ± 11.6
a 83.6 ± 16.6
a
Carbohydrates (% of
energy)
51.6 ± 8.8
a 54.3 ± 9.6
a 52.5 ± 7.9
a
Proteins (% of energy) 18.7 ± 5.1
a 19.9 ± 4.3
a 18.2 ± 5.8
a
Proteins (g/kg weight) 1.0 ± 0.4
a 0.9 ± 0.3
a 1.0 ± 0.4
a
Lipids (% of energy) 29.9 ± 8.7
a 27.2 ± 9.5
a 29.1 ± 6.1
a
SFA (% of energy) 8.3 ± 3.8
a 6.2 ± 2.3
a 7.2 ± 3.3
a
MUFA (% of energy) 9.0 ± 3.7
a 8.3 ± 3.8
a 8.6 ± 2.5
a
PUFA (% of energy) 6.9 ± 3.7
a 7.8 ± 4.7
a 7.9 ± 3.0
a
Cholesterol (mg) 162.6 ± 103.6
a 147.7 ± 70.5
a 206.0 ± 140.6
a
Fibers (g) 13.2 ± 7.5
a 16.0 ± 8.8
a 16.1 ± 9.0
a
Cereal (portions) 3.3 ± 1.5
a 3.5 ± 1.0
a 3.8 ± 1.4
a
Fruit (portions) 3.3 ± 3.0
a 3.8 ± 3.5
a 2.7 ± 3.0
a
Vegetables (portions) 2.4 ± 2.3
a 3.3 ± 2.9
a 3.2 ± 4.2
a
Legumes (portions) 0.8 ± 1.1
a 1.5 ± 1.7
b 1.5 ± 2.5
b
Dairy Products
(portions)
1.8 ± 1.3
a 1.5 ± 1.1
a 2.0 ± 1.6
a
Meat (portions) 1.8 ± 1.3
a 1.8 ± 1.2
a 1.8 ± 1.0
a
Sugar (portions) 1.7 ± 1.8
a 1.9 ± 2.5
a 1.8 ± 3.2
a
Oil (portions) 2.4 ± 2.3
a 2.2 ± 1.1
a 3.1 ± 2.1
a
Variety (item) 13.5 ± 3.7
a 14.2 ± 3.4
a 13.7 ± 4.4
a
Total cholesterol
(mg/dL)
203.8 ± 35.4
a 225.7 ± 49.4
b 201.3 ± 42.7
a
Glucose (mg/dL) 91.7 ± 18.2
a 95.4 ± 14.1
a 129.4 ± 50.2
b
Triglycerides (mg/dL) 140.8 ± 61.1
a 169.8 ± 70.1
b 172.7 ± 69.3
b
HDL-C (mg/dL) 52.7 ± 12.4
a 44.8 ± 9.3
b 45.7 ± 12.2
b
LDL-C (mg/dL) 122.9 ± 31.6
a 146.8 ± 46.0
b 121.0 ± 41.3
a
Urea ((mg/dL) 31.9 ± 9.6
a 33.4 ± 7.2
a 37.4 ± 18.7
b
Uric acid (mg/dL) 4.8 ± 1.3
a 5.9 ± 1.6
b 5.6 ± 1.5
b
g-GT (mg/dL) 31.8 ± 22.4
a 36.1 ± 18.9
a 32.1 ± 19.1
a
nHDL-C (mg/dL) 151.1 ± 35.4
a 180.8 ± 46.6
b 155.6 ± 44.7
a
CRP (mg/dL) 0.52 ± 0.57
a 0.29 ± 0.21
b 0.65 ± 0.96
a
SBP (mm/Hg) 124.6 ± 15.6
a 140.1 ± 16.8
b 131.4 ± 16.0
c
DBP (mm/Hg) 79.6 ± 8.9
a 84.1 ± 8.1
b 81.4 ± 6.0
b
CAD: coronary artery disease; BMI: body mass index; HEI: healthy eating index;
SFA: saturated fatty acid; MUFA: monounsaturated fat acid; PUFA:
polyunsaturated fatty acid; CAD: coronary artery disease; HDL-C: high-density
lipoprotein; LDL-C: low-density lipoprotein; nHDL-C: non high-density lipoprotein;
CRP: C-reactive protein; SBP: systolic blood pressure; DBP: diastolic blood pressure;
g-GT: g-glutamyl transferase. Different letters indicate significant differences
(p < 0.05).
Table 2 Significant correlation of demographic,
anthropometric, dietary and biochemical data with CAD
risk score (p < 0.05)
CAD Risk Score p Value
Age 0.420 <0.0001
% energy from Protein 0.309 0.012
Glucose 0.374 <0.0001
HDL-C -0.323 <0.0001
Uric acid 0.370 <0.0001
SBP 0.461 <0.0001
DBP 0.358 <0.0001
MS (number of components) 0.453 <0.0001
CAD: coronary artery disease; HDL-C: high-density lipoprotein; LDL-C: low-density
lipoprotein; nHDL-C: non high-density lipoprotein; SBP: systolic blood pressure;
DBP: diastolic blood pressure; MS: metabolic syndrome
Table 3 Odds ratio for CAD risk score according to
anthropometry, diet, MS, CRP and uric acid
concentrations
Model 1 Model 2
BMI (≥25 vs <25 kg/m
2) 1.540 (0.900-2.635) -
Waist circumference¹ 1.492 (0.939-2.372) 1.480 (0.828-2.647)
Muscle Mass IndexMI
2 0.333 (0.140-0.794)* 0.297 (0.110-0.799)*
% Body fat
3 1.437 (0.861-2.398) 1.394 (0.667-2.917)
MS
4 3.906 (2.450-6.250)* 4.276 (2.581-7.083)*
CRP (≥1.0 vs <1.0 mg/dL) 0.580 (0.220-1.531) 0.499 (0.180-1.380)
Uric acid
5 3.856 (1,190-12,493)* 3.552 (1.081-11.668)*
Saturated fat acids (<10%
vs ≥ 10% TCV)
0.301 (0.121-0.752)* 0.269 (0.098-0.378)*
Dietary fiber (≥ 20 vs <
20g/d)
0.309 (0.151-0.633)* 0.297 (0.132-0.668)*
Model 1: crude
Model 2: adjusted for BMI (for all variables) + TCV (for dietary variables)
95% CI; *p < 0.05; CAD: coronary artery disease; MS: metabolic syndrome; CRP:
C-reactive protein; BMI: body mass index,; ¹: cutoff points ♂ (>102 vs ≤102 cm)
and ♀ (>88 vs ≤88 cm);
2: cutoff points ♂ (≥10.75 vs <10.75 kg/m
2) and ♀
(≥6.75 vs <6.75 kg/m
2);
3: cutoff points ♂ (≥25 vs <25%) and ♀ (≥35 vs <35%);
4: presence vs absence;
5: cutoff points (♂ > 6,5 mg/dL and ♀ > 5 mg/dL).
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has been associated with cardiovascular disease and
other pathological processes [42]. Within this context,
UA has been assessed as an independent risk factor for
cardiovascular disease, but results are controversial
[43,44]. Our study showed that CAD risk score increases
with higher concentrations of UA. The ARIC study [45],
in which more than 13,500 individuals, including men
and women, participated, did not show any association
between hyperuricemia and CAD risk. A recent study
[46] conducted in Austria with more than 80,000 men
revealed a strong relationship between UA and risk fac-
tors for arteriosclerosis. The contradictory results may
be justified by methodological differences, such as indi-
viduals with a recent history of cardiopathy, use of med-
ications that can influence biochemical results, different
ethnic groups or social-economic status [43,45].
One possible, yet contested [47], pathophysiological
mechanism of the association between hyperuricemia
and CAD could occur by favoring plaque adhesiveness
and thus contribute towards atherogenesis and the for-
mation of blood thrombus [48].
A protective effect of muscle mass (MMI) on CAD
risk score was found. It is known that the genesis of sar-
copenia is associated with an increase in reactive species
of oxygen and oxidative stress [49], with a defined role
in different types of cardiovascular disease [50]. Wein-
brenner et al. [51], studied the relationship between oxi-
dized LDL and other oxidized stress markets with CAD.
The authors suggest that the reduction of oxidized LDL,
superoxide dismutase and glutathione peroxidase and
the increase in oxidized anti-LDL antibodies improves
oxidative stress in individuals with CAD.
As in previous studies [52,53], it was possible here to
observe the beneficial effects of the recommended intake
of SFA and dietary fiber on coronary risk. Jakobsen et al
[54] found a positive association between SFA intake
and CAD risk among men and women under 60 years
of age, but not among individuals over 60 years. In our
study the age over 60 seems to influence CAD risk.
A study conducted by Hu et al [55] on types of fat
and their relationship to coronary risk underscores the
isocaloric replacement of saturated fat with unsaturated
fat, which presents a beneficial effect on reducing CAD
risk. Our study did not reveal any relationship with
mono or polyunsaturated fat. Hu et al. [56] conducted a
study with more than 80,000 women between 34 and 59
years of age and found significant relations between
CAD risk and types of fat, underscoring the high intake
of saturated fat as a risk for CAD [56].
Our study observed that the percentage of energy
f r o mp r o t e i na n dt h ei n t a k eo fm e a ta r ec o r r e l a t e dt o
CAD risk. This is probably due to excess protein of ani-
mal origin and the consequent excess intake of saturated
fat with higher coronary risks. Individuals with the lower
CAD risk score had the lowest legume intake. They also
had the lowest caloric intake which could lead to a
lower amount of food intake, and a lower intake of
legumes.
The mechanism by which SFA influences CAD risk
would be by activating Toll-Like 4 receptors, which
through free fatty acids stimulate the inflammatory
response [57]. Studies have demonstrated the role of
inflammation in CAD and other complications [58,59].
The effects of dietary fiber on CAD risk occur through
various mechanisms, such as improved lipid standards
[60], reduced blood pressure [61] and improved insulin
sensitivity [62]. Pereira et al [63] suggest that dietary
fiber intake is inversely associated with CAD risk. In
this study, the authors indicate a 10 to 30% reduction in
coronary risk for every 10g/day of fiber from cereals and
fruit [63]. Soluble fiber and its relation to CAD risk has
also been shown in several studies [64,65]. Pietinen et al
[66] found an inverse association of soluble fiber with
CAD risk. In this study, we did not identify the main
dietary sources and fiber types and their possible rela-
tions with CAD risk score. A review identified 9 pro-
spective studies on the relation of dietary fiber with
CAD risk [67]. Among the studies, 7 found a negative
association of fiber intake with CAD risk, and 2 studies
presented controversial results [67].
In this paper, we studied the role of recommended
intake of SFA and dietary fiber on CAD risk score after
adjustments for TCV and BMI. The adjustment for total
energy intake is used to provide isocaloric conditions for
the studied sample [68]. Thus, the existing difference
between an individual with TCV of 3000 kcal and
another with 1000 kcal would be cancelled, considering
only the % of macronutrients. The adjustment for BMI
aims at eliminating the effects of adiposity on CAD risk
score. Thus, the adjustment for TCV and BMI in the
same model aims at annulling excess calories the obese
individual may have.
The limitations in this study were the type of study
and the food method record. It was a cross-sectional
study and some cause/effect relations cannot be proven,
only the presence or not of an association between the
factors. A single 24-hour dietary recall is based on foods
and amounts actually consumed by an individual on one
specific day, which has an important limitation for not
capture intra-individual variability in food intake. The
ideal procedure would be to apply the food method
record at least 3 days per week. Furthermore, other lim-
itation was the study sample; a drop-off of 45% could
reduce the impact of our results.
Another weak point was related with the muscle mass
quantification by BIA in which muscle mass is calcu-
lated from lean body mass which is complementary to
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low fat mass and fat mass is well known as pro-inflam-
matory and CAD risk factor.
Conclusion
In this study, recommended intake of saturated fats and
dietary fiber are, together with greater muscle mass,
inversely associated with CAD risk score. On the other
hand, the presence of MS and high plasma uric acid are
associated with CAD risk score.
Future proposals for intervention should consider life-
style changes with proper eating habits and physical
exercise (including hypertrophic performance).
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